Correlation Between Neuropace and MaxCyte

Can any of the company-specific risk be diversified away by investing in both Neuropace and MaxCyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and MaxCyte into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuropace and MaxCyte, you can compare the effects of market volatilities on Neuropace and MaxCyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of MaxCyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and MaxCyte.

Diversification Opportunities for Neuropace and MaxCyte

-0.39

Correlation Coefficient

Neuropace  MaxCyte

Very good diversification

The 3 months correlation between Neuropace and MaxCyte is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and MaxCyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MaxCyte and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with MaxCyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MaxCyte has no effect on the direction of Neuropace i.e., Neuropace and MaxCyte go up and down completely randomly.

Pair Corralation between Neuropace and MaxCyte

Given the investment horizon of 90 days Neuropace is expected to generate 1.62 times more return on investment than MaxCyte. However, Neuropace is 1.62 times more volatile than MaxCyte. It trades about 0.13 of its potential returns per unit of risk. MaxCyte is currently generating about -0.05 per unit of risk. If you would invest  739.00  in Neuropace on September 2, 2024 and sell it today you would earn a total of  321.00  from holding Neuropace or generate 43.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Neuropace  vs.  MaxCyte

Neuropace

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

MaxCyte

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MaxCyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Neuropace and MaxCyte

The main advantage of trading using opposite Neuropace and MaxCyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, MaxCyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MaxCyte will offset losses from the drop in MaxCyte's long position.

The idea behind Neuropace and MaxCyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.